Fundraising FoxRivia
Zurich, CH · 1 known investors
Find your way into Rivia
Sign up to see every warm intro you have to Rivia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rivia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Rivia provides a unified clinical trial data platform that helps biotechnology companies accelerate drug development and reduce costs through technology-enabled solutions for managing complex trial operations. The platform serves biotech firms bringing new therapies to market.
Founders & leadership
Investors · 1
Nina Capitallisted by Nina CapitalBarcelona · $215K – $1.6M
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Rivia do?
- Rivia provides a unified clinical trial data platform that helps biotechnology companies accelerate drug development and reduce costs through technology-enabled solutions for managing complex trial operations. The platform serves biotech firms bringing new therapies to market.
- Who founded Rivia?
- Rivia was founded by Erik Scalfaro, Tiago Kieliger.
- Who are Rivia's investors?
- Rivia's investors include Nina Capital.
- Where is Rivia headquartered?
- Rivia is headquartered in Zurich, CH.